Clinical Trial

Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder

Name: Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder — clinical trial record (NCT07029529)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

For this protocol, the investigators plan to collect data to evaluate apremilast (60mg/day) vs placebo in adults with Alcohol Use Disorders (AUD).

Protocol Amendment History 3 changes

critical Recruitment opened 2026-05-15

notable Enrollment reduced: 120 -> 80 participants 2026-04-08

minor Trial arms changed: 3 -> 2 2026-04-08

Trial Details

NCT Number	NCT07029529
Lead Sponsor	Yale University Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions	Alcohol Use Disorder
Enrollment	80 participants
Start Date	2026-05-12
Primary Completion	2030-08 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2026-06-08